PTC Therapeutics, Inc.
US ˙ NasdaqGS ˙ US69366J2006

SecurityPTCT / PTC Therapeutics, Inc.
InstitutionVerition Fund Management LLC
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Verition Fund Management LLC ownership in PTCT / PTC Therapeutics, Inc.

On May 15, 2026 - Verition Fund Management LLC filed a 13F-HR form disclosing ownership of 0 shares of PTC Therapeutics, Inc. (US:PTCT) valued at $0 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 20,200 shares of PTC Therapeutics, Inc.. The current value of the position is $0 USD.

Verition Fund Management LLC has a history of taking positions in derivatives of the underlying security (PTCT) in the form of stock options.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

PTCT / PTC Therapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F PTC THERAPEUTICS COM 69366J200 0 -100.00 0
2026-02-13 2025-12-31 13F PTC THERAPEUTICS COM 69366J200 20,200 -16,870 -45.51 1,534 -32.54 0.0060
2025-11-14 2025-09-30 13F PTC THERAPEUTICS COM 69366J200 37,070 -78,338 -67.88 2,275 -59.65 0.0094
2025-08-14 2025-06-30 13F PTC THERAPEUTICS COM 69366J200 115,408 80,005 225.98 5,637 212.42 0.0251
2025-05-15 2025-03-31 13F PTC THERAPEUTICS COM 69366J200 35,403 -6,483 -15.48 1,804 -4.55 0.0084
2025-02-14 2024-12-31 13F PTC THERAPEUTICS COM 69366J200 41,886 9,152 27.96 1,891 55.68 0.0075
2024-11-14 2024-09-30 13F PTC THERAPEUTICS COM 69366J200 32,734 1,669 5.37 1,214 27.92 0.0061
2024-08-14 2024-06-30 13F PTC THERAPEUTICS COM 69366J200 31,065 7,485 31.74 950 38.54 0.0052
2024-05-14 2024-03-31 13F PTC THERAPEUTICS COM 69366J200 23,580 -980 -3.99 686 1.33 0.0047
2024-02-14 2023-12-31 13F PTC THERAPEUTICS COM 69366J200 24,560 -674 -2.67 677 19.65 0.0053
2023-11-14 2023-09-30 13F PTC THERAPEUTICS COM 69366J200 25,234 -1,687 -6.27 565 -48.35 0.0066
2023-08-14 2023-06-30 13F PTC THERAPEUTICS COM 69366J200 26,921 3,897 16.93 1,095 -1.88 0.0146
2023-05-15 2023-03-31 13F PTC THERAPEUTICS COM 69366J200 23,024 -693 -2.92 1,115 23.20 0.0154
2023-02-14 2022-12-31 13F PTC THERAPEUTICS COM 69366J200 23,717 -1,057 -4.27 905 -27.25 0.0141
2023-01-18 2022-09-30 13F/A-1 PTC THERAPEUTICS COM 69366J200 24,774 -2,035 -7.59 1,244 15.83 0.0139
2022-11-14 2022-09-30 13F PTC THERAPEUTICS COM 69366J200 24,774 -2,035 1,244 0.0141
2022-08-30 2022-06-30 13F/A-1 PTC THERAPEUTICS COM 69366J200 26,809 26,809 1,074 0.0212
2022-08-15 2022-06-30 13F PTC THERAPEUTICS COM 69366J200 26,809 26,809 1,074 0.0182
2021-08-16 2021-06-30 13F PTC THERAPEUTICS COM 69366J200 0 -8,227 -100.00 0 -100.00
2021-05-18 2021-03-31 13F PTC THERAPEUTICS COM 69366J200 8,227 8,227 390 0.0044
2020-05-15 2020-03-31 13F PTC THERAPEUTICS COM 69366J200 0 -25,274 -100.00 0 -100.00
2020-02-14 2019-12-31 13F PTC THERAPEUTICS COM 69366J200 25,274 25,274 1,214 0.0221
2019-11-14 2019-09-30 13F PTC THERAPEUTICS COM 69366J200 0 -47,306 -100.00 0 -100.00
2019-08-14 2019-06-30 13F PTC THERAPEUTICS COM 69366J200 47,306 47,306 2,129 0.0599
2018-08-15 2018-06-30 13F PTC THERAPEUTICS COM 69366J200 0 -14,006 -100.00 0 -100.00
2018-05-15 2018-03-31 13F PTC THERAPEUTICS COM 69366J200 14,006 14,006 379 0.0282
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2020-05-15 2020-03-31 13F PTC THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-02-14 2019-12-31 13F PTC THERAPEUTICS COM Put 11,300 0.00 543 42.15 n/a n/a n/a
2019-11-14 2019-09-30 13F PTC THERAPEUTICS COM Put 11,300 382 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.